MONJUVI
MorphoSys AG
Mark For: MONJUVI® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88074194 |
| Registration Number | 6031814 |
| Mark Literal Elements | MONJUVI |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-04-14 |
| Basis | 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | Yes |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Michael J. Leonard |
| Attorney Docket Number | 114353.00048 |
| Law Office Assigned | N30 |
| Employee Name | INGOLD, GERALDINE F |
Timeline
| 2018-08-10 | Application Filed |
| 2019-07-16 | Published |
| 2019-07-16 | Published for Opposition |
| 2019-07-22 | Status: Live/Pending |
| 2019-11-20 | Location: PETITIONS OFFICE |
| 2019-11-20 | Transaction Date |
| 2020-04-14 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-04-14 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2020-04-14 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  MorphoSys AG |
| Address | Semmelweisstrasse 7 Planegg GERMANY D-82152 |
| Legal Entity Type | Aktiengesellschaft (ag) |
| Legal Entity State | GERMANY |
Documents
 Drawing | JPEG | 2018-08-10 |
 TEAS RF New Application | MULTI | 2018-08-10 |
| Preliminary Amendment | MULTI | 2018-09-09 |
| Amendment and Mail Process Complete | MULTI | 2018-09-19 |
| Preliminary Amendment | MULTI | 2018-11-15 |
| Amendment and Mail Process Complete | MULTI | 2018-11-21 |
| XSearch Search Summary | XML | 2018-11-29 |
| Offc Action Outgoing | XML | 2018-12-04 |
| Response to Office Action | APPLICATION/XML | 2019-05-31 |
| Amendment and Mail Process Complete | MULTI | 2019-06-04 |
| Amendment to Delete or Correct Basis | MULTI | 2019-06-05 |
| Examiners Amendment | XML | 2019-06-10 |
| Notation to File | XML | 2019-06-10 |
| Amendment and Mail Process Complete | MULTI | 2019-06-11 |
| TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2019-06-13 |
| Notice of Publication | XML | 2019-06-26 |
| Notification Of Notice of Publication | XML | 2019-06-26 |
| OG Publication Confirmation | XML | 2019-07-16 |
| Post Publication Amendment | XML | 2019-10-22 |
| Amendment and Mail Process Complete | MULTI | 2019-11-21 |
| Registration Certificate | 2020-04-14 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders
IC 042. US 100 101. G & S: Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders |
| GS0051 | Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2020-04-14 | |
| TTAB RELEASE CASE TO TRADEMARKS | 2020-03-07 | 253455 |
| OPPOSITION TERMINATED NO. 999999 | 2020-03-07 | 253455 |
| OPPOSITION DISMISSED NO. 999999 | 2020-03-07 | 253455 |
| OPPOSITION INSTITUTED NO. 999999 | 2020-01-13 | 253455 |
| CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2019-11-20 | 67832 |
| ASSIGNED TO PETITION STAFF | 2019-11-18 | 67832 |
| TEAS POST PUBLICATION AMENDMENT RECEIVED | 2019-10-22 | 1111 |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2019-07-22 | |
| PUBLISHED FOR OPPOSITION | 2019-07-16 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-07-16 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-06-26 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-06-12 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2019-06-10 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2019-06-10 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2019-06-10 | 94052 |
| EXAMINER'S AMENDMENT ENTERED | 2019-06-10 | 88888 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-06-01 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-05-31 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-05-31 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-12-04 | 6325 |
| NON-FINAL ACTION WRITTEN | 2018-12-04 | 94052 |
| NON-FINAL ACTION E-MAILED | 2018-12-04 | 6325 |
| ASSIGNED TO EXAMINER | 2018-11-28 | 94052 |
| PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | 2018-11-20 | 68123 |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2018-11-15 | |
| PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | 2018-09-18 | 68123 |
| ASSIGNED TO LIE | 2018-09-18 | 68123 |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2018-09-09 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-08-20 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-08-14 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MONJUVI 88682860 not registered Live/Pending |
MorphoSys AG 2019-11-06 |
 MONJUVI 88664626 not registered Live/Pending |
MorphoSys AG 2019-10-22 |
 MONJUVI 88074194 not registered Live/Pending |
MorphoSys AG 2018-08-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 